Activation of the renal Na + :Cl − cotransporter by angiotensin II is a WNK4-dependent process
Open Access
- 15 May 2012
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 109 (20), 7929-7934
- https://doi.org/10.1073/pnas.1200947109
Abstract
Pseudohypoaldosteronism type II is a salt-sensitive form of hypertension with hyperkalemia in humans caused by mutations in the with-no-lysine kinase 4 (WNK4). Several studies have shown that WNK4 modulates the activity of the renal Na(+)Cl(-) cotransporter, NCC. Because the renal consequences of WNK4 carrying pseudoaldosteronism type II mutations resemble the response to intravascular volume depletion (promotion of salt reabsorption without K(+) secretion), a condition that is associated with high angiotensin II (AngII) levels, it has been proposed that AngII signaling might affect WNK4 modulation of the NCC. In Xenopus laevis oocytes, WNK4 is required for modulation of NCC activity by AngII. To demonstrate that WNK4 is required in the AngII-mediated regulation of NCC in vivo, we used a total WNK4-knockout mouse strain (WNK4(-/-)). WNK4 mRNA and protein expression were absent in WNK4(-/-) mice, which exhibited a mild Gitelman-like syndrome, with normal blood pressure, increased plasma renin activity, and reduced NCC expression and phosphorylation at T-58. Immunohistochemistry revealed normal morphology of the distal convoluted tubule with reduced NCC expression. Low-salt diet or infusion of AngII for 4 d induced phosphorylation of STE20/SPS1-related proline/alanine-rich kinase (SPAK) and of NCC at S-383 and T-58, respectively, in WNK4(+/+) but not WNK4(-/-) mice. Thus, the absence of WNK4 in vivo precludes NCC and SPAK phosphorylation promoted by a low-salt diet or AngII infusion, suggesting that AngII action on the NCC occurs via a WNK4-SPAK-dependent signaling pathway. Additionally, stimulation of aldosterone secretion by AngII, but not by a high-K(+) diet, was impaired in WNK4(-/-) mice.This publication has 36 references indexed in Scilit:
- Disease-causing mutations in the acidic motif of WNK4 impair the sensitivity of WNK4 kinase to calcium ionsBiochemical and Biophysical Research Communications, 2012
- Role of AT1 receptor-mediated salt retention in angiotensin II-dependent hypertensionAmerican Journal of Physiology-Renal Physiology, 2011
- The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertensionNature Medicine, 2011
- A SPAK Isoform Switch Modulates Renal Salt Transport and Blood PressureCell Metabolism, 2011
- Serine-threonine kinase with-no-lysine 4 (WNK4) controls blood pressure via transient receptor potential canonical 3 (TRPC3) in the vasculatureProceedings of the National Academy of Sciences of the United States of America, 2011
- Role of the WNK‐activated SPAK kinase in regulating blood pressureEMBO Molecular Medicine, 2010
- The thiazide-sensitive Na+-Cl−cotransporter: molecular biology, functional properties, and regulation by WNKsAmerican Journal of Physiology-Renal Physiology, 2009
- Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathwayProceedings of the National Academy of Sciences of the United States of America, 2009
- WNK4 regulates activity of the epithelial Na + channel in vitro and in vivoProceedings of the National Academy of Sciences of the United States of America, 2007
- Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidneyProceedings of the National Academy of Sciences of the United States of America, 2006